IRIDEX Corp (IRIX) stock
IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
$0.69−0.02 (-2.75%)
Close on Nov 13, 2026Market cap $12.12MP/E –Yield –
Iridex EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Iridex's EPS for the twelve months ending Jul 4, 2026 was -$0.20. For fiscal 2025 it was -$0.26. The highest annual figure on record is $0.97 in fiscal 2014.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | -$0.26 | – |
| FY2024 | Dec 28, 2024 | -$0.54 | – |
| FY2023 | Dec 30, 2023 | -$0.59 | – |
| FY2022 | Dec 31, 2022 | -$0.47 | – |
| FY2021 | Jan 1, 2022 | -$0.34 | – |
| FY2020 | Jan 2, 2021 | -$0.46 | – |
| FY2019 | Dec 28, 2019 | -$0.64 | – |
| FY2018 | Dec 29, 2018 | -$1.05 | – |
| FY2017 | Dec 30, 2017 | -$1.11 | – |
| FY2016 | Dec 31, 2016 | -$1.15 | -2400.0% |
| FY2015 | Jan 2, 2016 | $0.05 | -94.8% |
| FY2014 | Jan 3, 2015 | $0.97 | +340.9% |
| FY2013 | Dec 28, 2013 | $0.22 | +37.5% |
| FY2012 | Dec 29, 2012 | $0.16 | -38.5% |
| FY2011 | Dec 31, 2011 | $0.26 | -13.3% |
| FY2010 | Jan 1, 2011 | $0.30 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | -$0.07 | – |
| Q1 FY2026 | Apr 4, 2026 | -$0.03 | – |
| Q4 FY2025 | Jan 3, 2026 | -$0.01 | – |
| Q3 FY2025 | Sep 27, 2025 | -$0.09 | – |
| Q2 FY2025 | Jun 28, 2025 | -$0.06 | – |
| Q1 FY2025 | Mar 29, 2025 | -$0.10 | – |
| Q4 FY2024 | Dec 28, 2024 | -$0.05 | – |
| Q3 FY2024 | Sep 28, 2024 | -$0.12 | – |
| Q2 FY2024 | Jun 29, 2024 | -$0.16 | – |
| Q1 FY2024 | Mar 30, 2024 | -$0.21 | – |
| Q4 FY2023 | Dec 30, 2023 | -$0.18 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.11 | – |
| Q2 FY2023 | Jul 1, 2023 | -$0.17 | – |
| Q1 FY2023 | Apr 1, 2023 | -$0.13 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.07 | – |
| Q3 FY2022 | Oct 1, 2022 | -$0.11 | – |
| Q2 FY2022 | Jul 2, 2022 | -$0.14 | -255.6% |
| Q1 FY2022 | Apr 2, 2022 | -$0.15 | – |
| Q4 FY2021 | Jan 1, 2022 | -$0.15 | – |
| Q3 FY2021 | Oct 2, 2021 | -$0.14 | – |
| Q2 FY2021 | Jul 3, 2021 | $0.09 | – |
| Q1 FY2021 | Apr 3, 2021 | -$0.14 | – |
| Q4 FY2020 | Jan 2, 2021 | -$0.01 | – |
| Q3 FY2020 | Sep 26, 2020 | -$0.12 | – |
| Q2 FY2020 | Jun 27, 2020 | -$0.20 | – |
| Q1 FY2020 | Mar 28, 2020 | -$0.12 | – |
| Q4 FY2019 | Dec 28, 2019 | -$0.11 | – |
| Q3 FY2019 | Sep 28, 2019 | -$0.13 | – |
| Q2 FY2019 | Jun 29, 2019 | -$0.18 | – |
| Q1 FY2019 | Mar 30, 2019 | -$0.22 | – |
| Q4 FY2018 | Dec 29, 2018 | -$0.21 | – |
| Q3 FY2018 | Sep 29, 2018 | -$0.26 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.28 | – |
| Q1 FY2018 | Mar 31, 2018 | -$0.31 | – |
| Q4 FY2017 | Dec 30, 2017 | -$0.44 | – |
| Q3 FY2017 | Sep 30, 2017 | -$0.27 | – |
| Q2 FY2017 | Jul 1, 2017 | -$0.24 | – |
| Q1 FY2017 | Apr 1, 2017 | -$0.16 | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.04 | – |
| Q3 FY2016 | Oct 1, 2016 | -$0.07 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?